FiercePharma  Oct 13  Comment 
AZ taps 3SBio to help drive sales of diabetes meds Byetta, Bydureon in China phil Thu, 10/13/2016 - 10:00
Reuters  Jun 7  Comment 
* 3Sbio will make total contributions of $10 million to joint venture
GenEng News  Jul 24  Comment 
3SBio said today it has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), less than a month after completing the largest IPO of the first half of 2015. 3SBio said the acquisition will enhance its capabilities by...
Reuters  May 27  Comment 
* 3SBIO offers 484.9 mln new shares, CITIC PE 121.2 mln shares



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki